Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Multiple sclerosis.
Resting-state functional connectivity in multiple sclerosis: An examination of group differences and individual differences.
Synergistic effects of atorvastatin and all-trans retinoic acid in ameliorating animal model of multiple sclerosis.
Menopause in multiple sclerosis: therapeutic considerations.
Glatiramer acetate: a review of its use in patients with relapsing-remitting multiple sclerosis and in delaying the onset of clinically definite multiple sclerosis.
Study of fatigue frequency and its association with sociodemographic and clinical variables in patients with multiple sclerosis.
Biology of the blood-nerve barrier and its alteration in immune mediated neuropathies.
The role of chromogranin B in an animal model of multiple sclerosis.
Multiple sclerosis and mitochondrial gene variations: A review.
Electroconvulsive therapy in patient with psychotic depression and multiple sclerosis.
Abundant kif21b is associated with accelerated progression in neurodegenerative diseases.
Complement activation and expression during chronic relapsing experimental autoimmune encephalomyelitis in the Biozzi ABH mouse.
Association between the CD24 Ala57Val polymorphism and risk for multiple sclerosis and systemic lupus erythematosus: a meta-analysis.
'The only certain measure of the effectiveness of multiple sclerosis therapy is cerebrospinal neurofilament level - YES'.
Deletion of Mitochondrial Anchoring Protects Dysmyelinating Shiverer: Implications for Progressive MS.
Autonomic dysfunction in multiple sclerosis.
Specific Depletion of Myelin-Reactive B Cells via BCR-Targeting.
The Ifng Gene Is Essential for Vdr Gene Expression and Vitamin D3-Mediated Reduction of the Pathogenic T Cell Burden in the Central Nervous System in Experimental Autoimmune Encephalomyelitis, a Multiple Sclerosis Model.
Burden of illness in multiple sclerosis (DEFENSE) study: the costs and quality-of-life of Finnish patients with multiple sclerosis.
CLINICAL PROBLEM-SOLVING. A Breakthrough Diagnosis.
Isolated anti-β2-glycoprotein I antibodies in neurology: a frontier syndrome between multiple sclerosis and antiphospholipid syndrome?
CD8+-dependent CNS demyelination following ocular infection of mice with a recombinant HSV-1 expressing murine IL-2.
Effects of Bacille Calmette-Guérin after the first demyelinating event in the CNS.
Jitter of corticospinal neurons during repetitive transcranial magnetic stimulation. Method and possible clinical implications.
Environmental Pathology: SY09-2 MULTIPLE SCLEROSIS (MS) AND NEURODEGENERATION: CAUSE AND PATHOGENESIS IN RELATION TO ELECTROMAGNETIC FIELDS (EMF).
Pages
« first
‹ previous
…
476
477
478
479
480
481
482
483
484
…
next ›
last »